A Study of SHR-1918 In Participants With Hypertriglyceridemia

A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 367 participants.

Also called NCT07349615

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 367 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT07349615
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Active, not recruiting (from the registry)

Technical summary

Registry record NCT07349615. Randomized; quadruple masking; primary purpose treatment. Start 2026-03-31 (actual); primary completion 2027-03 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study of SHR-1918 In Participants With Hypertriglyceridemia
Condition
Hypertriglyceridemia
Intervention (Drug)
SHR-1918/ SHR-1918 placebo
Intervention (Drug)
SHR-1918/ SHR-1918 placebo
Lead sponsor
Beijing Suncadia Pharmaceuticals Co., Ltd (class: industry)

Record details

Record id
cardio:ct-nct07349615
Content hash
09f97d1210401a9ba30871a2316c7e9f2f6f1fa0001598fdcaf22e5d295fb06f